Your browser doesn't support javascript.
loading
Plasma concentrations of persistent organic pollutants and pancreatic cancer risk.
Porta, Miquel; Gasull, Magda; Pumarega, José; Kiviranta, Hannu; Rantakokko, Panu; Raaschou-Nielsen, Ole; Bergdahl, Ingvar A; Sandanger, Torkjel Manning; Agudo, Antoni; Rylander, Charlotta; Nøst, Therese Haugdahl; Donat-Vargas, Carolina; Aune, Dagfinn; Heath, Alicia K; Cirera, Lluís; Goñi-Irigoyen, Fernando; Alguacil, Juan; Giménez-Robert, Àlex; Tjønneland, Anne; Sund, Malin; Overvad, Kim; Mancini, Francesca Romana; Rebours, Vinciane; Boutron-Ruault, Marie-Christine; Kaaks, Rudolf; Schulze, Matthias B; Trichopoulou, Antonia; Palli, Domenico; Grioni, Sara; Tumino, Rosario; Naccarati, Alessio; Panico, Salvatore; Vermeulen, Roel; Quirós, J Ramón; Rodríguez-Barranco, Miguel; Colorado-Yohar, Sandra M; Chirlaque, María-Dolores; Ardanaz, Eva; Wareham, Nick; Key, Tim; Johansson, Mattias; Murphy, Neil; Ferrari, Pietro; Huybrechts, Inge; Chajes, Veronique; Gonzalez, Carlos Alberto; Bueno-de-Mesquita, Bas; Gunter, Marc; Weiderpass, Elisabete; Riboli, Elio.
Affiliation
  • Porta M; Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain.
  • Gasull M; Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Pumarega J; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Kiviranta H; Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain.
  • Rantakokko P; Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Raaschou-Nielsen O; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Bergdahl IA; Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain.
  • Sandanger TM; Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Agudo A; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Rylander C; Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland.
  • Nøst TH; Department of Health Security, National Institute for Health and Welfare, Kuopio, Finland.
  • Donat-Vargas C; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Aune D; Department of Biobank Research, Umeå University, Umeå, Sweden.
  • Heath AK; Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Cirera L; Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Goñi-Irigoyen F; Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Alguacil J; Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Giménez-Robert À; Department of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Tjønneland A; Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Sund M; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid, CEI UAM+CSIC, Madrid, Spain.
  • Overvad K; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Mancini FR; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Rebours V; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Boutron-Ruault MC; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Kaaks R; Department of Health and Social Sciences, University of Murcia, Murcia, Spain.
  • Schulze MB; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Trichopoulou A; Health Department of Basque Government, Public Health Laboratory in Gipuzkoa, San Sebastian, Spain.
  • Palli D; Health Research Institute Biodonostia, San Sebastian, Spain.
  • Grioni S; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Tumino R; University of Huelva, Huelva, Spain.
  • Naccarati A; Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain.
  • Panico S; Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Vermeulen R; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Quirós JR; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
  • Rodríguez-Barranco M; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Colorado-Yohar SM; CESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France.
  • Chirlaque MD; Inserm UMR1018, Institut Gustave Roussy, Villejuif, France.
  • Ardanaz E; Pancreatology Department, Beaujon Hospital, AP-HP, Clichy, France.
  • Wareham N; Inserm UMR1149, DHU Unit, Paris-Diderot University, Paris, France.
  • Key T; CESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France.
  • Johansson M; Inserm UMR1018, Institut Gustave Roussy, Villejuif, France.
  • Murphy N; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ferrari P; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam, Rehbruecke, Nuthetal, Germany.
  • Huybrechts I; Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.
  • Chajes V; Hellenic Health Foundation, Athens, Greece.
  • Gonzalez CA; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.
  • Bueno-de-Mesquita B; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Gunter M; Cancer Registry and Histopathology Department, "Civic-M.P. Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.
  • Weiderpass E; Molecular and Genetic Epidemiology Unit, Italian Institute for Genomic Medicine (IIGM), Turin, Italy.
  • Riboli E; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Int J Epidemiol ; 51(2): 479-490, 2022 05 09.
Article in En | MEDLINE | ID: mdl-34259837
ABSTRACT

BACKGROUND:

Findings and limitations of previous studies on persistent organic pollutants (POPs) and pancreatic cancer risk support conducting further research in prospective cohorts.

METHODS:

We conducted a prospective case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Participants were 513 pancreatic cancer cases and 1020 matched controls. Concentrations of 22 POPs were measured in plasma collected at baseline.

RESULTS:

Some associations were observed at higher concentrations of p, p'-DDT, trans-nonachlor, ß-hexachlorocyclohexane and the sum of six organochlorine pesticides and of 16 POPs. The odds ratio (OR) for the upper quartile of trans-nonachlor was 1.55 (95% confidence interval 1.06-2.26; P for trend = 0.025). Associations were stronger in the groups predefined as most valid (participants having fasted >6 h, with microscopic diagnostic confirmation, normal weight, and never smokers), and as most relevant (follow-up ≥10 years). Among participants having fasted >6 h, the ORs were relevant for 10 of 11 exposures. Higher ORs were also observed among cases with microscopic confirmation than in cases with a clinical diagnosis, and among normal-weight participants than in the rest of participants. Among participants with a follow-up ≥10 years, estimates were higher than in participants with a shorter follow-up (for trans-nonachlor OR = 2.14, 1.01 to 4.53, P for trend = 0.035). Overall, trans-nonachlor, three PCBs and the two sums of POPs were the exposures most clearly associated with pancreatic cancer risk.

CONCLUSIONS:

Individually or in combination, most of the 22 POPs analysed did not or only moderately increased the risk of pancreatic cancer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Pesticides / Polychlorinated Biphenyls / Environmental Pollutants Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Epidemiol Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Pesticides / Polychlorinated Biphenyls / Environmental Pollutants Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Epidemiol Year: 2022 Document type: Article Affiliation country: